Quick Answer
BiomX Inc. reported Stockholders Equity of -$1.30 million for the year ending 2025.
- BiomX Inc. showed a decrease of -105.4% in Stockholders Equity from 2024 to 2025.
- This data is from BiomX Inc.'s annual report (Form 10-K), filed with the SEC on February 19, 2026.
- XBRL data for this metric is available from 2017 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $24.0 thousand | Q2 2018: $24.0 thousand | Q3 2018: $23.3 thousand | Q1 2019: $41.68 million | Q2 2019: $38.23 million | Q3 2019: $34.26 million | Q1 2020: $79.00 million | Q2 2020: $73.52 million | Q3 2020: $65.84 million | Q1 2021: $53.95 million | Q2 2021: $48.59 million | Q3 2021: $53.43 million | Q1 2022: $40.02 million | Q2 2022: $32.74 million | Q3 2022: $26.56 million | Q1 2023: $16.15 million | Q2 2023: $15.87 million | Q3 2023: $8.15 million | Q1 2024: -$9.54 million | Q2 2024: $27.43 million | Q3 2024: $37.90 million | Q1 2025: $24.50 million | Q2 2025: $19.16 million | Q3 2025: $10.49 million.
- Over the full 11 years of available data (2017 to 2025), BiomX Inc.'s Stockholders Equity has declined by 111.3%.
- Historical annual values: Fiscal year 2025: -$1.30 million | Fiscal year 2024: $24.15 million | Fiscal year 2023: $3.08 million | Fiscal year 2022: $21.04 million | Fiscal year 2021: $47.54 million | Fiscal year 2020: $57.47 million | Fiscal year 2019: $84.46 million | Fiscal year 2019: $5.00 million | Fiscal year 2018: $42.80 million | Fiscal year 2018: $24.0 thousand | Fiscal year 2017: $11.53 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: